A novel anti-rheumatic drug suppresses tumor necrosis factor-α and augments interleukin-10 in adjuvant arthritic rats
- 15 December 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 409 (3) , 331-335
- https://doi.org/10.1016/s0014-2999(00)00866-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A novel dual regulator of tumor necrosis factor-α and interleukin-10 protects mice from endotoxin-induced shockEuropean Journal of Pharmacology, 2000
- Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-αJournal of Medicinal Chemistry, 1999
- Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppressionClinical and Experimental Immunology, 1999
- Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study GroupGastroenterology, 1997
- Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNFα processingInflammation Research, 1997
- Cellular adhesion molecules in rat adjuvant arthritisArthritis & Rheumatism, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Interleukin‐10 inhibition of the progression of established collagen‐induced arthritisArthritis & Rheumatism, 1996
- Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritisClinical and Experimental Immunology, 1995
- Elevated levels of TNF in the joints of adjuvant arthritic ratsCytokine, 1993